Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$619M |
| 2 |
Citigroup
C
|
+$457M |
| 3 |
Cimpress
CMPR
|
+$379M |
| 4 |
Broadcom
AVGO
|
+$374M |
| 5 |
Apple
AAPL
|
+$287M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$348M |
| 2 |
Microsoft
MSFT
|
+$331M |
| 3 |
IQVIA
IQV
|
+$243M |
| 4 |
Costco
COST
|
+$193M |
| 5 |
St. Joe Company
JOE
|
+$168M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.21% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 13.77% |
| 4 | Industrials | 12.77% |
| 5 | Consumer Discretionary | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
ServiceNow
NOW
$102B
| $104M | 0.07% |
4,414,670
+112,030
| +3% | +$2.49M |
|
|
XEC
352
DELISTED
CIMAREX ENERGY CO
XEC
| $103M | 0.07% |
909,181
+74,868
| +9% | +$7.47M |
|
|
HI
353
DELISTED
Hillenbrand
HI
| $103M | 0.07% |
2,648,772
+240,920
| +10% | +$8.75M |
|
354
Ligand Pharmaceuticals
LGND
$6.02B
| $103M | 0.07% |
1,209,771
+255,199
| +27% | +$20.2M |
|
355
Integra LifeSciences
IART
$1.54B
| $103M | 0.07% |
2,035,288
-20,625
| -1% | -$1.06M |
|
356
HealthEquity
HQY
$7.91B
| $102M | 0.07% |
2,020,291
-92,739
| -4% | -$4.32M |
|
357
Visteon
VC
$2.77B
| $102M | 0.07% |
825,572
+55,325
| +7% | +$6.27M |
|
358
Prologis
PLD
$138B
| $102M | 0.07% |
1,609,961
-375,717
| -19% | -$23.1M |
|
359
Southwest Airlines
LUV
$22.1B
| $102M | 0.07% |
1,821,985
+1,151,371
| +172% | +$64.6M |
|
|
MGP
360
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $102M | 0.07% |
3,374,355
-759,016
| -18% | -$22.8M |
|
361
Kennametal
KMT
$2.68B
| $101M | 0.06% |
2,509,518
+474,225
| +23% | +$17.5M |
|
362
Aramark
ARMK
$15B
| $101M | 0.06% |
3,431,835
-492,734
| -13% | -$14.3M |
|
363
GE Aerospace
GE
$367B
| $100M | 0.06% |
866,526
-103,043
| -11% | -$12.5M |
|
364
Packaging Corp of America
PKG
$22.7B
| $100M | 0.06% |
873,664
+275,933
| +46% | +$30.9M |
|
365
NetEase
NTES
$76.5B
| $100M | 0.06% |
1,896,635
-72,715
| -4% | -$4.18M |
|
|
AVXS
366
DELISTED
AveXis, Inc. Common Stock
AVXS
| $99.4M | 0.06% |
1,027,221
+352,456
| +52% | +$31.8M |
|
367
Canadian Natural Resources
CNQ
$96.9B
| $98.3M | 0.06% |
5,992,084
+900,524
| +18% | +$13.8M |
|
368
CDW
CDW
$17.1B
| $97.8M | 0.06% |
1,481,602
-373,606
| -20% | -$23.4M |
|
369
Protolabs
PRLB
$1.86B
| $97.7M | 0.06% |
1,217,196
-84,233
| -6% | -$6.09M |
|
370
Cal-Maine
CALM
$4.28B
| $97.1M | 0.06% |
2,361,375
+383,193
| +19% | +$14.3M |
|
371
Domino's
DPZ
$11B
| $96.8M | 0.06% |
487,761
+77,202
| +19% | +$15M |
|
372
Compass Minerals
CMP
$1.24B
| $96.5M | 0.06% |
1,486,825
+361,985
| +32% | +$24.2M |
|
373
Stanley Black & Decker
SWK
$14.2B
| $95.8M | 0.06% |
634,640
+542,555
| +589% | +$78M |
|
374
Simpson Manufacturing
SSD
$7.98B
| $95.2M | 0.06% |
1,941,044
+277,496
| +17% | +$12.4M |
|
375
Etsy
ETSY
$7.65B
| $95.1M | 0.06% |
5,633,003
-719,736
| -11% | -$11.4M |
|
Similar funds
Janus Henderson Group's Q3 2017 Portfolio in Review
As of Q3 2017, Janus Henderson Group held 1,386 positions worth $156B, up 5.9% from $147B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Janus Henderson Group's Q3 2017 filing shows 78 new, 598 increased, 569 reduced and 102 closed positions. Its largest new stake was Medtronic: 7,457,362 shares worth $580M. The largest sale was Reynolds American Inc, an estimated $348M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2017 buy was Medtronic: 7,457,362 shares worth $580M.
- Janus Henderson Group added most to Citigroup in Q3 2017, an estimated $457M increase.
- Janus Henderson Group's biggest Q3 2017 reduction was Microsoft, cutting an estimated $331M.
- Janus Henderson Group fully exited Reynolds American Inc in Q3 2017, selling an estimated $348M.
- Janus Henderson Group's ten largest holdings make up 14% of its $156B portfolio in Q3 2017.
- Janus Henderson Group opened 78 new positions and closed 102 in Q3 2017.
- Janus Henderson Group's portfolio value rose 5.9% quarter-over-quarter to $156B.
Based on Janus Henderson Group's 13F filing for Q3 2017, filed 14 Nov 2017.